Learning Objectives:
1. Recognize the role of international consortia to understand the genetic architecture of Parkinson's disease
2. Describe the role of genetics in identifying molecular mechanisms and novel treatment targets
3. Appreciate how patient-specific genetic data is guiding therapeutic strategies and drug development